Wolverine Trading
AVIR icon

Wolverine Trading’s Atea Pharmaceuticals AVIR Stock Holding History

Wolverine Trading’s Portfolio AVIR Stock Details AVIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$43.7K Sell
14,982
-747
-5% -$2.55K ﹤0.01% 5445
2025
Q2 		$54.3K Buy
+15,729
New +$46.9K ﹤0.01% 4329
2024
Q2 		– Sell
-21,163
Closed -$85.5K – 4459
2024
Q1 		$85.5K Buy
21,163
+7,289
+53% +$28.5K ﹤0.01% 4093
2023
Q4 		$42.3K Buy
+13,874
New +$42K ﹤0.01% 4292
2022
Q2 		– Sell
-11,487
Closed -$81K – 4479
2022
Q1 		$81K Buy
+11,487
New +$78K ﹤0.01% 4903

Other funds holding AVIR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Wolverine Trading's AVIR Position: Q3 2025 in Review

Wolverine Trading reduced its Atea Pharmaceuticals (AVIR) stake by 4.7% in Q3 2025, selling an estimated $2.55K and leaving 14,982 shares worth $43.7K. The position accounts for ﹤0.01% of the portfolio, ranked #5445.

Wolverine Trading first reported a position in AVIR in Q1 2022 and has held it in 5 quarters since. The position peaked at $85.5K in Q1 2024. 115 funds tracked by Wall St. Rank hold AVIR as of Q3 2025.

  • Wolverine Trading held 14,982 shares of Atea Pharmaceuticals worth $43.7K as of Q3 2025.
  • Wolverine Trading sold 747 Atea Pharmaceuticals shares in Q3 2025, an estimated $2.55K.
  • Atea Pharmaceuticals made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #5445 holding.
  • Wolverine Trading first reported a position in Atea Pharmaceuticals in Q1 2022 and has held it in 5 quarters since.
  • Wolverine Trading's Atea Pharmaceuticals position peaked at $85.5K in Q1 2024.
  • 115 funds tracked by Wall St. Rank held Atea Pharmaceuticals as of Q3 2025.

Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.